Your browser version may not work well with NCBI's Web applications. More information here...
1: Blood. 2008 Jan 15;111(2):968-9.Click here to read Links

High-risk myeloma: a gene expression based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone.

PMID: 18182586 [PubMed - indexed for MEDLINE]

PMCID: PMC2200846 [Available on 01/15/09]